Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCB vs LA/Remifentanil for EVAR
NCT03443518Phase 2Completed
- Sponsor
- Dr. Erfan and Bagedo General Hospital
- Start
- Feb 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine hydrochloride 0.75% injection in abdominal aortic aneurysm (AAA), sponsored by Dr. Erfan and Bagedo General Hospital. Started Feb 2018; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT03443518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03443518.